{"TopicDetails": {"type": 0, "ccm2Id": 31071910, "cftId": 0, "identifier": "IMI2-2015-06-04", "title": "Development of an outcomes-focused data platform to empower policy makers and clinicians to optimize care for patients with hematologic malignancies", "publicationDateLong": 1444089600000, "callIdentifier": "H2020-JTI-IMI2-2015-06-two-stage", "callTitle": "H2020-JTI-IMI2-2015-06-two-stage", "callccm2Id": 31071911, "allowPartnerSearch": true, "frameworkProgramme": {"id": 31045243, "abbreviation": "H2020", "description": "Horizon 2020 Framework Programme"}, "programmeDivision": [{"id": 31047894, "abbreviation": "EU.3.1.", "description": "Health, demographic change and wellbeing"}, {"id": 31047893, "abbreviation": "EU.3.", "description": "Societal Challenges"}, {"id": 31045244, "abbreviation": "EC", "description": "EC Treaty"}], "topicMGAs": [], "tags": ["haematology", "registries"], "keywords": ["Registries", "Haematology"], "sme": false, "actions": [{"status": {"id": 31094503, "abbreviation": "Closed", "description": "Closed"}, "types": [{"typeOfAction": "IMI2-RIA Research and Innovation action", "typeOfMGA": []}], "plannedOpeningDate": "06 October 2015", "submissionProcedure": {"id": 31094505, "abbreviation": "two-stage", "description": "two-stage"}, "deadlineDates": ["12 January 2016", "14 June 2016"]}], "latestInfos": [], "budgetOverviewJSONItem": {"budgetTopicActionMap": {"3235090": [{"action": "IMI2-2015-06-03 - IMI2-RIA Research and Innovation action", "plannedOpeningDate": "06 October 2015", "deadlineModel": "two-stage", "deadlineDates": ["12 January 2016", "14 June 2016"], "budgetYearMap": {"2016": 93000000}, "budgetTopicActionMap": {}}, {"action": "IMI2-2015-06-01 - IMI2-RIA Research and Innovation action", "plannedOpeningDate": "06 October 2015", "deadlineModel": "two-stage", "deadlineDates": ["12 January 2016", "14 June 2016"], "budgetYearMap": {"2016": 93000000}, "budgetTopicActionMap": {}}, {"action": "IMI2-2015-06-02 - IMI2-RIA Research and Innovation action", "plannedOpeningDate": "06 October 2015", "deadlineModel": "two-stage", "deadlineDates": ["12 January 2016", "14 June 2016"], "budgetYearMap": {"2016": 93000000}, "budgetTopicActionMap": {}}, {"action": "IMI2-2015-06-04 - IMI2-RIA Research and Innovation action", "plannedOpeningDate": "06 October 2015", "deadlineModel": "two-stage", "deadlineDates": ["12 January 2016", "14 June 2016"], "budgetYearMap": {"2016": 93000000}, "budgetTopicActionMap": {}}]}, "budgetYearsColumns": ["2016"]}, "description": "<SPAN class=\"topicdescriptionkind\">Specific Challenge</SPAN>:<p>Hematologic malignancies (HMs) account for about one-third of cancer cases in children and about one-third of cancer deaths. Due to the rarity of the conditions and the diverse healthcare practice across EU, current healthcare systems are challenged with</p><ul level=\"0\">  <li>lack of definition and alignment on outcomes</li>  <li>policy makers having limited benchmark data to evaluate the risk/benefit ratio and value,</li>  <li>clinicians having to make treatment choices based on short-term, surrogate and often not comparable data</li>  <li>payers having the need to make reimbursement decisions on life prolonging options with limited data and finite budgets.</li> </ul><p>This can lead to patients not having access to the right treatment at the right time.</p>\n<SPAN class=\"topicdescriptionkind\">Scope</SPAN>:<p>Key objectives include:</p><ul level=\"0\">  <li>define standard sets of outcomes for HMs that are relevant and meaningful to patients and clinicians</li>  <li>communicate and support the use of the defined standard outcomes data sets on selected HMs</li>  <li>develop a data sharing platform that empowers clinicians and policy stakeholders to improve decision making</li>  <li>propel key medical and policy initiatives through fact based decisions based on large, diverse harmonised data sets.</li> </ul>\n<SPAN class=\"topicdescriptionkind\">Expected Impact</SPAN>:<p>Improved clinical development based on clear definition of endpoints, outcome measures leading to consistent assessments across EU;</p><ul level=\"0\">  <li>better understanding of the natural history of the diseases;</li>  <li>ability to prove the value, safety and effectiveness of therapies, therefore faster patient access to these therapies.</li> </ul>\n", "conditions": "<p>Please read carefully all provisions below before the preparation of your application.<br />\r\n&nbsp;<br />\r\nThe budget breakdown for this call is given at the end of the Call topics text, in the <a href=\"http://ec.europa.eu/research/participants/data/ref/h2020/other/call_fiches/jtis/h2020-call-fiche15-6-imi2-ju_en.pdf\">Call Conditions </a>section, as well as the following information :</p>\r\n<ol>\r\n    <li><strong><span style=\"color: rgb(0,51,102)\">List of countries and applicable rules for funding</span></strong><br />\r\n    &nbsp;</li>\r\n    <li><strong><span style=\"color: rgb(0,51,102)\">Eligibility and admissibility conditions</span></strong><br />\r\n    &nbsp;</li>\r\n    <li><strong><span style=\"color: rgb(0,51,102)\">Evaluation </span></strong><strong><span style=\"color: rgb(0,51,102)\">criteria and procedure, scoring and threshold:</span></strong> described in&nbsp;the <u><a href=\"http://ec.europa.eu/research/participants/data/ref/h2020/other/guides_for_applicants/jtis/h2020-guide-pse-v1.1-imi-ju_en.pdf\"><u>IMI2&nbsp;Manual for&nbsp;submission, envaluation and grant award</u></a><br />\r\n    </u>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</li>\r\n    <li><span style=\"color: rgb(0,51,102)\"><strong>Indicative timetable for evaluation and grant agreement</strong></span><br />\r\n    &nbsp;</li>\r\n    <li><strong><span style=\"color: rgb(0,51,102)\">Provisions, proposal templates and evaluation forms for the type(s) of action(s) under this topic: </span></strong><br />\r\n    <br />\r\n    <u>IMI2 Research and Innovation Action (IMI2-RIA) and (IMI2-IA):</u><br />\r\n    <br />\r\n    <a href=\"http://ec.europa.eu/research/participants/data/ref/h2020/other/guides_for_applicants/jtis/h2020-guide-rel-prov-imi-ju_en.pdf\">Summary of the most relevant provisions for participating in IMI2 actions</a><br />\r\n    <a href=\"http://ec.europa.eu/research/participants/data/ref/h2020/other/call_ptef/pt/h2020-call-pt-imi2-ria_en.pdf\">Standard proposal template </a><br />\r\n    <a href=\"http://ec.europa.eu/research/participants/data/ref/h2020/other/call_ptef/ef/h2020-call-ef-imi2-ria_en.pdf\">Standard evaluation form</a><br />\r\n    <a href=\"http://ec.europa.eu/research/participants/data/ref/h2020/other/mga/jtis/h2020-mga-imi_en.pdf\">IMI2 Model Grant Agreement</a><br />\r\n    <a href=\"http://ec.europa.eu/research/participants/portal/doc/call/h2020/h2020-phc-2015-two-stage/1620124-essential_information_for_clinical_studies_2015callsv2_18082014_en.pdf\">Template for essential clinial trial information</a><br />\r\n    &nbsp;</li>\r\n</ol>", "supportInfo": "<p><strong>Contact the IMI&nbsp;Programme Office - E-mail: <a href=\"mailto:infodesk@imi.europa.eu\">infodesk@imi.europa.eu</a> - Tel: +32 2 221 81 81</strong><br />\r\n<br />\r\nContact the <strong>SOFIA&nbsp;IT&nbsp;Helpdesk </strong>for questions such as forgotten passwords, access rights and roles, technical aspects of submission of proposals, etc - E-mail: <strong><a href=\"mailto:sofia@imi.europa.eu\">sofia@imi.europa.eu</a> </strong></p>\r\n<p><strong><a href=\"http://www.imi.europa.eu/content/partner-search\">IMI Partner Search Tool </a></strong>helps you find a partner organisation for your proposal</p>\r\n<p><strong><span><a href=\"http://ec.europa.eu/research/participants/portal4/desktop/en/support/national_contact_points.html\">National Contact Points (NCP)</a>&nbsp;-&nbsp;</span></strong><span>contact your NCP for further assistance.</span><br />\r\n<strong><br />\r\n<span><a href=\"http://ec.europa.eu/research/index.cfm?lg=en&amp;pg=enquiries\">Research Enquiry Service</a></span></strong><span> &ndash; ask questions about any aspect of European research in general and the EU Research Framework Programmes in particular.</span><br />\r\n<a href=\"http://een.ec.europa.eu/\"><br />\r\n<strong>Enterprise Europe Network</strong></a> &ndash; contact your EEN national contact for advice to businesses with special focus on SMEs. The support includes guidance on the EU research funding.<br />\r\n<a href=\"http://ec.europa.eu/research/participants/api/contact/index.html\"><br />\r\n<strong>IT Helpdesk</strong></a>- contact the Participant Portal IT helpdesk for questions such as forgotten passwords, access rights and roles, technical aspects of submission of proposals, etc.<br />\r\n<a href=\"http://www.imi.europa.eu/content/states-representatives-groups\"><br />\r\n<strong>IMI States Representative Group (SRG)</strong></a> &ndash; contact you SRG member for assistance.<br />\r\n<strong><br />\r\nIMI JU <a href=\"mailto:sofia@imi.europa.eu\">IT Helpdesk</a></strong> &ndash; for IMI2 topics contact the SOFIA IT helpdesk for questions such as forgotten passwords, access rights and roles, technical aspects of submission of proposals, etc.<br />\r\n<strong><br />\r\nEthics</strong> &ndash; for compliance with ethical issues, see the<a href=\"http://ec.europa.eu/research/participants/docs/h2020-funding-guide/cross-cutting-issues/ethics_en.htm\"> Participant Portal</a>&nbsp;and&nbsp;<a href=\"http://ec.europa.eu/research/science-society/index.cfm?fuseaction=public.topic&amp;id=1289&amp;lang=1\">Science and Society Portal</a><br />\r\n<a href=\"http://www.cen.eu/cen/Services/Innovation/Pages/default.aspx\"><br />\r\n<strong>CEN</strong></a> and <a href=\"http://www.cenelec.eu/aboutcenelec/whatwestandfor/fosterinnovation/randd.html\"><strong>CENELEC</strong></a>, the European Standards Organisations, advise you how to tackle standardisation in your project proposal. Contact CEN-CENELEC Research Helpdesk at <a href=\"mailto:research@cencenelec.eu\">research@cencenelec.eu</a>.<br />\r\n<a href=\"http://www.imi.europa.eu/content/partner-search\"><br />\r\n</a><br />\r\n&nbsp;</p>", "sepTemplate": "<p>To access the Electronic Submission Service of the topic, please select the <strong>type of action</strong> that is most relevant to your proposal from the list below and click on the <strong>'Start Submission' </strong>button. You will then be asked to confirm your choice of the type of action and topic, as these cannot be changed in the submission system. Upon confirmation you will be linked to the correct entry point.</p>\r\n<p>To access existing draft proposals for this topic, please login to the Participant Portal and select the My Proposals page of the My Area section.</p>", "links": [{"callIdentifier": "H2020-JTI-IMI2-2015-06-two-stage", "status": "Closed", "criterionType": "SubFundingScheme", "criterionTypeDescription": "subfunding schemes", "criterionCode": "IMI2-RIA", "criterionDescription": "Research and Innovation action", "url": "https://sofia.imi.europa.eu/Pages/Login.aspx?ReturnUrl=%2fPages%2fDefault.aspx", "startDate": "Nov 10, 2015 11:40:27 AM"}], "additionalDossiers": [], "infoPackDossiers": [], "callDetailsJSONItem": {"latestInfos": [{"approvalDate": "Nov 10, 2015 12:04:29 PM", "lastChangeDate": "Nov 10, 2015 12:04:29 PM", "content": "The submission session is now available for: IMI2-2015-06-01(IMI2-RIA), IMI2-2015-06-02(IMI2-RIA), IMI2-2015-06-03(IMI2-RIA), IMI2-2015-06-04(IMI2-RIA)"}], "hasForthcomingTopics": false, "hasOpenTopics": false, "allClosedTopics": true}}}